Showing results (241-250 of 331) with videos related to

Sort By:
Pageof 34
Scientific Reports|February 18, 2017
Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular carcinoma: a retrospective studyAndrea Casadei Gardini, Flavia Foca, Mario Scartozzi, et al.
Updates in Surgery|July 24, 2023
Ten years of Italian mini-invasiveness: the I Go MILS registry as a tool of dissemination, characterization and networkingFrancesca Ratti, Alessandro Ferrero, Alfredo Guglielmi, et al.
Oncotarget|October 15, 2017
Antiangiogenic agents after first line and sorafenib plus chemoembolization: a systematic reviewAndrea Casadei Gardini, Daniele Santini, Giuseppe Aprile, et al.
Journal of Geriatric Oncology|September 8, 2019
GOSAFE - Geriatric Oncology Surgical Assessment and Functional rEcovery after Surgery: early analysis on 977 patientsIsacco Montroni, Siri Rostoft, Antonino Spinelli, et al.
Hepato-Gastroenterology|December 24, 2008
A new liver transplant priority for patients with hepatocellular carcinomaMatteo Ravaioli, Gian Luca Grazi, Gaetano Vetrone, et al.
Updates in Surgery|July 26, 2015
Salvage liver transplantation after laparoscopic resection for hepatocellular carcinoma: a multicenter experienceEmanuele Felli, Umberto Cillo, Antonio Daniele Pinna, et al.
Annals of Hepatology|May 27, 2020
Is there an association between commonly employed biomarkers of liver fibrosis and liver stiffness in the general population?Francesco Giuseppe Foschi, Marco Domenicali, Pierluigi Giacomoni, et al.
Journal of Hepatology|March 24, 2020
Including mRECIST in the Metroticket 2.0 criteria improves prediction of hepatocellular carcinoma-related death after liver transplantAlessandro Cucchetti, Matteo Serenari, Carlo Sposito, et al.
Journal of Clinical Medicine|February 4, 2021
External Validation of Surrogate Indices of Fatty Liver in the General Population: the Bagnacavallo StudyFrancesco Giuseppe Foschi, Fabio Conti, Marco Domenicali, et al.
Pageof 34